Therefore, overexpression of USP25 not only attenuates tumor growth but also potentiates the therapeutic efficacy of ICB in HNSCC by suppressing the recruitment of MDSCs and improving the functionality of CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.